news & events




November 2015

Drug Discovery Innovation Program

Dr. Paolo Lombardi, CEO of Naxospharma and former collaborator of Aromics will attend at the Drug Discovery Innovation Programme (DDIP), to be held on November 25-26, 2015 in Munich, Germany.


November 2015

Advances in Berberine antitumor agents

Dr. Lombardi, CEO de Naxospharma, a formal collaborator of AROMICS, will present the recent advances on the use of Berberine for the treatment of càncer. Presentation will take place at the 8th Global Summit in Cancer Therapies, that will take place in Valencia next 3rd to 5th November 2015.


August 2015

La Vanguardia: Biotechnology companies working on minoritary diseases

Article published at La Vanguardia newspaper: The biotechnology companies search novel therapies for minoritary diseases. This is the case of AROMICS' new development for the treatment of malignant mesothelioma, a rare tumor frequently related to work exposure to asbestos. (read the complete article at press release section)


July 2015

AROMICS particpated at SIMCC 2015

Dr. Carmen Plasencia participated in the Spanish-Italian Medicinal Chemistry Congress SIMCC2015, that took place from 12 to 15th July 2015 at Biomedicine Research Park of Barcelona.

4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12